References
- Baumgart DC, Carding SR. (2007). Inflammatory bowel disease: cause and immunobiology. The Lancet, 369, 1627–1640.
- Conrad K, Roggenbuck D, Laass MW. (2014). Diagnosis and classification of ulcerative colitis. Autoimmun Rev, 13, 463–466.
- Craft JE. (2012). Follicular helper T cells in immunity and systemic autoimmunity. Nat Rev Rheumatol, 8, 337–347.
- Elyaman W, Bassil R, Bradshaw EM, et al. (2012). Notch receptors and Smad3 signaling cooperate in the induction of interleukin-9-producing T cells. Immunity, 36, 623–634.
- Gerlach K, Andrew N M, Neurath MF, Weigmann B. (2015). IL-9 regulates intestinal barrier function in experimental T cell-mediated colitis. Tissue Barriers, 3, e983777.
- Gerlach K, Hwang Y, Nikolaev A, et al. (2014). TH9 cells that express the transcription factor PU. 1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells. Nat Immunol, 15, 676–686.
- Goswami R, Kaplan MH. (2011). A brief history of IL-9. J Immunol, 186, 3283–3288.
- Hufford MM, Kaplan MH. (2014). A gut reaction to IL-9. Nat Immunol, 15, 599–600.
- Kaplan MH. (2013). Th9 cells: differentiation and disease. Immunol Rev, 252, 104–115.
- Kawamata S, Matsuzaki K, Murata M, et al. (2010). Oncogenic Smad3 signaling induced by chronic inflammation is an early event in ulcerative colitis-associated carcinogenesis. Inflamm Bowel Dis, 17, 683–695.
- Leong RWL. (2010). Environmental risk factors in inflammatory bowel disease. J Gastroenterol Hepatol, 25, 227–228.
- Lewis JD, Chuai S, Nessel L, et al. (2008). Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis, 14, 1660–1666.
- Murphy SF, Kwon JH, Boone DL. (2012). Novel players in inflammatory bowel disease pathogenesis. Curr Gastroenterol Rep, 14, 146–152.
- Murugaiyan G, Beynon V, Cunha APD, et al. (2012). IFN-γ limits Th9-mediated autoimmune inflammation through dendritic cell modulation of IL-27. J Immunol, 189, 5277–5283.
- Nalleweg N, Chiriac MT, Podstawa E, et al. (2014). IL-9 and its receptor are predominantly involved in the pathogenesis of UC. Gut, 64, 743–55.
- Orholm M, Munkholm P, Langholz E, et al. (1991). Familial occurrence of inflammatory bowel disease. New England Journal of Medicine, 324, 84–88.
- Ouyang H, Shi Y, Liu Z, et al. (2013). Increased interleukin‑9 and CD4+ IL-9+ T cells in patients with systemic lupus erythematosus. Mol Med Rep, 7, 1031–1037.
- Perumal NB, Kaplan MH. (2011). Regulating IL9 transcription in T helper cells. Trends Immunol, 32, 146–150.
- Satsangi J1, Silverberg MS, Vermeire S, Colombel J. (2006). The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut, 55, 749–753.
- Silverberg MS, Satsangi J, Ahmad T, et al. (2005). Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol Hepatol, 19, 5A–36A.
- Stassen M, Schmitt E, Bopp T. (2012). From interleukin‐9 to T helper 9 cells. Ann N Y Acad Sci, 1247, 56–68.
- Staudt V, Bothur E, Klein M, et al. (2010). Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity, 33, 192–202.
- Tamiya T, Ichiyama K, Kotani H, et al. (2013). Smad2/3 and IRF4 play a cooperative role in IL-9–producing T cell induction. J Immunol, 191, 2360–2371.
- Van Klinken BJW, Van Der Wal JWG, Einerhand AWC, et al. (1999). Sulphation and secretion of the predominant secretory human colonic mucin MUC2 in ulcerative colitis. Gut, 44, 387–393.
- Wang A, Pan D, Lee Y-H, et al. (2013). Cutting edge: Smad2 and Smad4 regulate TGF-β-mediated Il9 Gene expression via EZH2 displacement. J Immunol, 191, 4908–4912.
- Yanaba K, Yoshizaki A, Asano Y, et al. (2011). Serum interleukin 9 levels are increased in patients with systemic sclerosis: association with lower frequency and severity of pulmonary fibrosis. J Rheumatol, 38, 2193–2197.